Format

Send to

Choose Destination
Clin Infect Dis. 2008 Nov 1;47(9):1226-30. doi: 10.1086/592302.

Drug toxicity, HIV progression, or comorbidity of aging: does tipranavir use increase the risk of intracranial hemorrhage?

Author information

1
Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut 06516, USA.

Abstract

The US Food and Drug Administration has issued a warning that tipranavir may be associated with increased risk of intracranial hemorrhage. We studied 2 large cohorts to estimate the background rate of intracranial hemorrhage and compared it with rates reported among persons who had been exposed to tipranavir.

PMID:
18831696
DOI:
10.1086/592302
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center